# Aripiprazole Added on for DMDD in Youths With ADHD

> **NCT03358277** · NA · COMPLETED · sponsor: **Tri-Service General Hospital** · enrollment: 58 (actual)

## Conditions studied

- Disruptive Mood Dysregulation Disorder

## Interventions

- **DRUG:** MPH + APZ

## Key facts

- **NCT ID:** NCT03358277
- **Lead sponsor:** Tri-Service General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-19
- **Primary completion:** 2017-08-12
- **Final completion:** 2017-08-12
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2017-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03358277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03358277, "Aripiprazole Added on for DMDD in Youths With ADHD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03358277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*